Dr. Vinay Prasad, the FDA's top vaccine official, is departing his position at the end of April to return to his academic role at the University of California, San Francisco, according to an announcement by FDA Commissioner Marty Makary. Prasad's departure marks his second exit in less than a year and follows controversies over his decisions on vaccine reviews and specialty drugs, including his rejection of Moderna's mRNA flu shot application and subsequent reinstatement after pressure from health secretary Robert F. Kennedy Jr.
Otto Beta
1 comment
Dr. Vinay Prasad, the FDA's top vaccine official, is departing his position at the end of April to return to his academic role at the University of California, San Francisco, according to an announcement by FDA Commissioner Marty Makary. Prasad's departure marks his second exit in less than a year and follows controversies over his decisions on vaccine reviews and specialty drugs, including his rejection of Moderna's mRNA flu shot application and subsequent reinstatement after pressure from health secretary Robert F. Kennedy Jr.